Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).
Publication
, Conference
Gasparetto, C; Lentzsch, S; Schiller, GJ; Callander, NS; Tuchman, S; Bahlis, NJ; White, D; Chen, C; Baljevic, M; Sutherland, HJ; Kotb, R ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gasparetto, C., Lentzsch, S., Schiller, G. J., Callander, N. S., Tuchman, S., Bahlis, N. J., … Lipe, B. (2020). Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Gasparetto, Cristina, Suzanne Lentzsch, Gary J. Schiller, Natalie Scott Callander, Sascha Tuchman, Nizar J. Bahlis, Darrell White, et al. “Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Gasparetto C, Lentzsch S, Schiller GJ, Callander NS, Tuchman S, Bahlis NJ, et al. Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM). In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Gasparetto, Cristina, et al. “Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Gasparetto C, Lentzsch S, Schiller GJ, Callander NS, Tuchman S, Bahlis NJ, White D, Chen C, Baljevic M, Sutherland HJ, Kotb R, Sebag M, LeBlanc R, Venner CP, Bensinger W, Rossi AC, Sheehan H, Arazy M, Kai K, Lipe B. Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM). JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences